Top Markets
Coin of the day
Medtronic plc Medtronic plc

Medtronic plc

2M6
Classement en actions #164
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Prix de l'action
$88.89
Capitalisation boursière
$114.13B
Changement (1 jour)
-0.93%
Changement (1 an)
-2.08%
Pays
IE
Échange Medtronic plc (2M6)

Catégorie

Revenus pour Medtronic plc (2M6)
Revenus en Jan 2026 TTM : $35.49B
Selon les derniers rapports financiers de Medtronic plc, le chiffre d'affaires actuel de l'entreprise (TTM) est de $35.49B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $32.36B une augmentation par rapport à le chiffre d'affaires de l'année 2023, qui était de $31.23B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Medtronic plc de 2000 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $35.49B 5.83%
2025 $33.54B 3.62%
2024 $32.36B 3.64%
2023 $31.23B -1.45%
2022 $31.69B 5.21%
2021 $30.12B 4.16%
2020 $28.91B -5.38%
2019 $30.56B 2.02%
2018 $29.95B 0.82%
2017 $29.71B 3.04%
2016 $28.83B 42.31%
2015 $20.26B 19.15%
2014 $17.01B 2.50%
2013 $16.59B 2.51%
2012 $16.18B 1.58%
2011 $15.93B 0.73%
2010 $15.82B 8.34%
2009 $14.60B 8.02%
2008 $13.52B 9.89%
2007 $12.30B 8.92%
2006 $11.29B 12.31%
2005 $10.05B 10.65%
2004 $9.09B 18.55%
2003 $7.67B 19.57%
2002 $6.41B 15.47%
2001 $5.55B 10.71%
2000 $5.01B 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
$44.33B 24.90%
US
$25.12B -29.23%
US
$35.48B -0.02%
IE
$20.08B -43.44%
US
$25.70B -27.60%
DE